Jay Loeffler

Q: What Schools Are Affiliated With Jay Loeffler

Jay Loeffler is affiliated with the following schools: Williams College, Stanford University, Johns Hopkins University, Massachusetts General Hospital, Harvard University

Jay Loeffler's AcademicInfluence.com Rankings

Jay Loeffler

Philosophy

#4913

World Rank

#7590

Historical Rank

#1357

USA Rank

Logic

#2404

World Rank

#3390

Historical Rank

#577

USA Rank

philosophy Degrees

Download Badge

Philosophy

Jay Loeffler's Degrees

Doctorate Medicine Harvard University
PhD Biomedical Engineering Johns Hopkins University

Why Is Jay Loeffler Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Jay Steven Loeffler was an American physician at Massachusetts General Hospital where he served as Chair of the Department of Radiation Oncology since 2000. He was the Herman and Joan Suit Professor of Radiation Oncology and Professor of Neurosurgery at Harvard Medical School.

(See a Problem?)

Jay Loeffler's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients. (2007) (1754)
Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05. (2000) (1365)
Angiogenesis in brain tumours (2007) (1303)
Relative biological effectiveness (RBE) values for proton beam therapy. (2002) (1170)
Lessons from phase III clinical trials on anti-VEGF therapy for cancer (2006) (1078)
Management of brain metastases. (1999) (708)
Meta‐analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults (1993) (614)
Charged particles in radiation oncology (2010) (587)
Stereotactic radiosurgery for the definitive, noninvasive treatment of brain metastases. (1995) (585)
Biomarkers of response and resistance to antiangiogenic therapy (2009) (554)
Insulin-like growth factor receptor I mediates resistance to anti-epidermal growth factor receptor therapy in primary human glioblastoma cells through continued activation of phosphoinositide 3-kinase signaling. (2002) (542)
A multiinstitutional outcome and prognostic factor analysis of radiosurgery for resectable single brain metastasis. (1996) (506)
Cellular-telephone use and brain tumors. (2001) (503)
Phase II study of cediranib, an oral pan-vascular endothelial growth factor receptor tyrosine kinase inhibitor, in patients with recurrent glioblastoma. (2010) (494)
Tolerance of cranial nerves of the cavernous sinus to radiosurgery. (1993) (464)
The role of stereotactic radiosurgery in the management of patients with newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline (2009) (461)
The biology of brain metastases—translation to new therapies (2011) (432)
Phase II trial of the antiangiogenic agent thalidomide in patients with recurrent high-grade gliomas. (2000) (420)
Proton beam therapy (2005) (390)
The role of surgical resection in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline (2009) (367)
The prognostic significance of phosphatidylinositol 3-kinase pathway activation in human gliomas. (2004) (363)
Charged particle therapy—optimization, challenges and future directions (2013) (356)
Patient study of in vivo verification of beam delivery and range, using positron emission tomography and computed tomography imaging after proton therapy. (2007) (355)
Advantage of protons compared to conventional X-ray or IMRT in the treatment of a pediatric patient with medulloblastoma. (2004) (347)
Improved tumor oxygenation and survival in glioblastoma patients who show increased blood perfusion after cediranib and chemoradiation (2013) (314)
Comparison of stereotactic radiosurgery and brachytherapy in the treatment of recurrent glioblastoma multiforme. (1995) (293)
The treatment of recurrent brain metastases with stereotactic radiosurgery. (1990) (287)
Charged-particle therapy in cancer: clinical uses and future perspectives (2017) (286)
The role of whole brain radiation therapy in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline (2009) (280)
The role of steroids in the management of brain metastases: a systematic review and evidence-based clinical practice guideline (2009) (275)
Quantitatively determined survivin expression levels are of prognostic value in human gliomas. (2002) (268)
Radiosurgery for the treatment of previously irradiated recurrent primary brain tumors and brain metastases: initial report of radiation therapy oncology group protocol (90-05). (1996) (261)
Variables associated with the development of complications from radiosurgery of intracranial tumors. (1991) (258)
Radiosurgery as part of the initial management of patients with malignant gliomas. (1992) (251)
Stereotactic radiosurgery for pituitary adenomas: an intermediate review of its safety, efficacy, and role in the neurosurgical treatment armamentarium. (2005) (244)
Central nervous system cancers. (2005) (238)
Treatment of patients with primary glioblastoma multiforme with standard postoperative radiotherapy and radiosurgical boost: prognostic factors and long-term outcome. (1999) (220)
Survivin enhances radiation resistance in primary human glioblastoma cells via caspase-independent mechanisms (2004) (213)
The epidermal growth factor receptor pathway mediates resistance to sequential administration of radiation and chemotherapy in primary human glioblastoma cells in a RAS-dependent manner. (2002) (209)
Temozolomide-Mediated Radiation Enhancement in Glioblastoma: A Report on Underlying Mechanisms (2006) (208)
Results of whole-brain radiation as salvage of methotrexate failure for immunocompetent patients with primary CNS lymphoma. (2005) (207)
Adult Medulloblastoma: Prognostic Factors and Patterns of Relapse (2000) (207)
Adaptation and verification of the relocatable Gill-Thomas-Cosman frame in stereotactic radiotherapy. (1994) (200)
Proton beam radiation therapy for skull base adenoid cystic carcinoma. (2006) (193)
Brain tumor cells in circulation are enriched for mesenchymal gene expression. (2014) (193)
Initial clinical results of LINAC-based stereotactic radiosurgery and stereotactic radiotherapy for pituitary adenomas. (1998) (193)
Results of Multimodality Treatment for 141 Patients with Brain Arteriovenous Malformations and Seizures: Factors Associated with Seizure Incidence and Seizure Outcomes (2002) (192)
Multidisciplinary management of brain metastases. (2007) (187)
Second Tumors after Radiosurgery: Tip of the Iceberg or a Bump in the Road? (2003) (187)
VEGF inhibitors in the treatment of cerebral edema in patients with brain cancer (2009) (181)
Criteria for the definition of Pituitary Tumor Centers of Excellence (PTCOE): A Pituitary Society Statement (2017) (179)
Brain tumors across the age spectrum: biology, therapy, and late effects. (2010) (171)
Central Nervous System Cancers, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology. (2020) (170)
Radiosurgery in the initial management of malignant gliomas: survival comparison with the RTOG recursive partitioning analysis. Radiation Therapy Oncology Group. (1995) (170)
Safety of combining radiotherapy with immune-checkpoint inhibition (2018) (168)
Medulloblastoma at the joint center for radiation therapy between 1968 and 1984. The influence of radiation dose on the patterns of failure and survival (1988) (167)
Image fusion for stereotactic radiotherapy and radiosurgery treatment planning. (1994) (166)
Radiation necrosis vs high-grade recurrent glioma: differentiation by using dual-isotope SPECT with 201TI and 99mTc-HMPAO. (1991) (165)
Hypothalamic/pituitary function following high-dose conformal radiotherapy to the base of skull: demonstration of a dose-effect relationship using dose-volume histogram analysis. (2001) (164)
Complications of therapy for venous thromboembolic disease in patients with brain tumors (1993) (160)
Primary lymphomas of the central nervous system: patterns of failure and factors that influence survival. (1985) (159)
Clinical patterns of failure following stereotactic interstitial irradiation for malignant gliomas. (1990) (157)
Stereotactic radiosurgery for intracranial arteriovenous malformations using a standard linear accelerator. (1989) (155)
Magnetic resonance image-directed stereotactic neurosurgery: use of image fusion with computerized tomography to enhance spatial accuracy. (1995) (154)
Radiation therapy in the management of pituitary adenomas. (2011) (150)
The role of chemotherapy in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline (2009) (148)
In vivo 3-T MR spectroscopy in the distinction of recurrent glioma versus radiation effects: initial experience. (2002) (146)
Primary CNS lymphoma. (2006) (145)
Low-grade gliomas. (2014) (142)
Lessons from anti-vascular endothelial growth factor and anti-vascular endothelial growth factor receptor trials in patients with glioblastoma. (2015) (139)
Results of stereotactic brachytherapy used in the initial management of patients with glioblastoma. (1990) (137)
Definitive radiation therapy in the management of symptomatic patients with optic glioma. Survival and long‐term effects (1990) (133)
Proton Beams to Replace Photon Beams in Radical Dose Treatments (2003) (133)
Survival after brain metastases from breast cancer in the trastuzumab era. (2005) (130)
The role of retreatment in the management of recurrent/progressive brain metastases: a systematic review and evidence-based clinical practice guideline (2009) (129)
DNA repair gene polymorphisms and risk of adult meningioma, glioma, and acoustic neuroma. (2010) (128)
Contemporary approaches to the treatment of malignant gliomas with radiation therapy. (1994) (122)
The effect of nonmalignant systemic disease on tolerance to radiation therapy. (2002) (121)
Treatment planning for stereotactic radiosurgery of intra-cranial lesions. (1991) (121)
Intracranial germinoma: the case for lower dose radiation therapy. (1997) (120)
NCCN task force: clinical utility of PET in a variety of tumor types. (2009) (119)
The role of prophylactic anticonvulsants in the management of brain metastases: a systematic review and evidence-based clinical practice guideline (2009) (118)
Gemcitabine-induced radiation recall. (2002) (117)
Long term results of stereotactic brachytherapy used in the initial treatment of patients with glioblastomas (1994) (117)
The radiobiology of radiosurgery. (1993) (116)
Central nervous system cancers, version 1.2017 featured updates to the NCCN guidelines (2017) (115)
Permanent alopecia after cranial irradiation: dose-response relationship. (2004) (114)
Fractionated stereotactic radiotherapy for the treatment of acoustic neuromas: preliminary results. (1996) (114)
Prognostic and pathologic significance of quantitative protein expression profiling in human gliomas. (2001) (113)
Results of linear accelerator-based radiosurgery for intracranial meningiomas. (1998) (113)
Stereotactic Radiotherapy for Vestibular Schwannomas: Favorable Outcome with Minimal Toxicity (2005) (111)
Proton Beam Radiosurgery for Vestibular Schwannoma: Tumor Control and Cranial Nerve Toxicity (2003) (109)
Dynamic field shaping for stereotactic radiosurgery: a modeling study. (1993) (108)
Detection of recurrent gliomas with quantitative thallium-201/technetium-99m HMPAO single-photon emission computerized tomography. (1992) (108)
Multimodality treatment of nongalenic arteriovenous malformations in pediatric patients. (2000) (108)
Integrative radiogenomic profiling of squamous cell lung cancer. (2013) (106)
Neurocognitive assessment following whole brain radiation therapy and radiosurgery for patients with cerebral metastases (2013) (102)
Proton stereotactic radiotherapy for persistent adrenocorticotropin-producing adenomas. (2008) (102)
Oxidative response gene polymorphisms and risk of adult brain tumors. (2008) (101)
NCCN Guidelines Insights: Central Nervous System Cancers, Version 1.2017. (2017) (101)
Proton therapy for low‐grade gliomas: Results from a prospective trial (2015) (100)
Polymorphisms in Apoptosis and Cell Cycle Control Genes and Risk of Brain Tumors in Adults (2007) (100)
Central Nervous System Cancers, Version 1.2015. (2015) (99)
Radiosurgery for hemangioblastoma: results of a multiinstitutional experience. (1996) (99)
Sociodemographic indicators and risk of brain tumours. (2003) (97)
Computer-assisted superimposition of magnetic resonance and high-resolution technetium-99m-HMPAO and thallium-201 SPECT images of the brain. (1991) (92)
Should positive phase III clinical trial data be required before proton beam therapy is more widely adopted? No. (2008) (92)
Imaging and extent of surgical resection predict risk of meningioma recurrence better than WHO histopathological grade. (2015) (92)
Stereotactic radiosurgery of the brain using a standard linear accelerator: a study of early and late effects. (1990) (92)
The accuracy of predicting survival in individual patients with cancer. (2014) (89)
Quality assurance in stereotactic radiosurgery using a standard linear accelerator. (1991) (88)
The change in patterns of relapse in medulloblastoma (1991) (88)
Outcomes of proton therapy for patients with functional pituitary adenomas. (2014) (85)
A report of the consensus workshop panel on the treatment of brain metastases. (1992) (85)
Visual outcome and tumor control after conformal radiotherapy for patients with optic nerve sheath meningioma. (2007) (84)
Pneumocystis carinii pneumonia during steroid taper in patients with primary brain tumors. (1993) (83)
In vitro radiosensitivity of human diploid fibroblasts derived from women with unusually sensitive clinical responses to definitive radiation therapy for breast cancer. (1990) (83)
Erlotinib for Progressive Vestibular Schwannoma in Neurofibromatosis 2 Patients (2010) (82)
Radiation Treatment for WHO Grade II and III Meningiomas (2013) (80)
Role of stereotactic radiosurgery with a linear accelerator in treatment of intracranial arteriovenous malformations and tumors in children. (1990) (80)
Lead, Genetic Susceptibility, and Risk of Adult Brain Tumors (2006) (80)
Emergency prebiopsy radiation for mediastinal masses: impact on subsequent pathologic diagnosis and outcome. (1986) (77)
Linac Radiosurgery for Skull Base Meningiomas (2001) (76)
Benign meningiomas (WHO Grade I) with atypical histological features: correlation of histopathological features with clinical outcomes. (2016) (76)
"Radiobiology of Proton Therapy": Results of an international expert workshop. (2018) (75)
Central nervous system cancers, version 2.2014. Featured updates to the NCCN Guidelines. (2014) (73)
Significance of targeted therapy and genetic alterations in EGFR, ALK, or KRAS on survival in patients with non-small cell lung cancer treated with radiotherapy for brain metastases. (2015) (73)
Aggressive Surgery and Focal Radiation in the Management of Meningiomas of the Skull Base: Preservation of Function with Maintenance of Local Control (2001) (72)
Stereotactic radiation treatment for benign meningiomas. (2007) (72)
Results of radiosurgery in the management of recurrent and residual medulloblastoma. (1995) (72)
Dose-volume prediction of radiation-related complications after proton beam radiosurgery for cerebral arteriovenous malformations. (2003) (71)
Judicious Resection and/or Radiosurgery for Parasagittal Meningiomas: Outcomes from a Multicenter Review (1998) (69)
Extremity preservation by combined modality therapy in sarcomas of the hand and foot: an analysis of local control, disease free survival and functional result. (1983) (68)
Proton radiation therapy for primary sphenoid sinus malignancies: Treatment outcome and prognostic factors (2009) (68)
Proton stereotactic radiosurgery in management of persistent acromegaly. (2007) (66)
Three ways to make proton therapy affordable (2017) (65)
Outcomes after whole brain reirradiation in patients with brain metastases. (2010) (64)
Radiosurgery in the management of pediatric brain tumors. (2001) (63)
Growth hormone deficiency is associated with decreased quality of life in patients with prior acromegaly. (2009) (60)
Allergic Skin Reactions to Anticonvulsant Medications in Patients Receiving Cranial Radiation Therapy (1999) (60)
The role of stereotactic radiosurgery in the management of intracranial tumors. (1990) (60)
Systemic Metastasis in Glioblastoma May Represent the Emergence of Neoplastic Subclones (2000) (59)
Proton beam stereotactic radiosurgery of vestibular schwannomas. (2002) (59)
Proton stereotactic radiosurgery for the treatment of benign meningiomas. (2011) (58)
Radiosurgery using a modified linear accelerator. (1992) (57)
Primary lymphoma of bone in children: analysis of treatment results with adriamycin, prednisone, Oncovin (APO), and local radiation therapy. (1986) (57)
A Comparison of Critical Structure Dose and Toxicity Risks in Patients with Low Grade Gliomas Treated with IMRT versus Proton Radiation Therapy (2009) (56)
The potential role of proton beams in radiation oncology. (1997) (55)
Magnetic resonance imaging changes after stereotactic radiation therapy for childhood low grade astrocytoma (1996) (53)
Bone involvement predicts poor outcome in atypical meningioma. (2009) (53)
Current radiosurgery practice: results of an ASTRO survey. Task Force on Stereotactic Radiosurgery, American Society for Therapeutic Radiology and Oncology. (1994) (52)
Neurocognitive effects of proton radiation therapy in adults with low-grade glioma (2015) (51)
BRAF alteration status and the histone H3F3A gene K27M mutation segregate spinal cord astrocytoma histology (2015) (51)
Radiation therapy in the management of pituitary adenomas. (2014) (51)
Proton radiosurgery in neurosurgery. (2007) (50)
Dual-isotope single-photon emission computerized tomography scanning in patients with glioblastoma multiforme: association with patient survival and histopathological characteristics of tumor after high-dose radiotherapy. (1998) (49)
Stereotactic radiosurgery for intracranial malignancies. (1994) (49)
Projected second tumor risk and dose to neurocognitive structures after proton versus photon radiotherapy for benign meningioma. (2012) (49)
Pre-radiation chemotherapy for infants and poor prognosis children with medulloblastoma. (1988) (47)
Suggested response criteria for phase II antitumor drug studies for neurofibromatosis type 2 related vestibular schwannoma (2009) (47)
Proton Beam Radiation Therapy (2006) (46)
The role of emerging and investigational therapies for metastatic brain tumors: a systematic review and evidence-based clinical practice guideline of selected topics (2009) (44)
Radiosurgery for primary malignant brain tumors. (1998) (44)
Radiation therapy in acromegaly (2008) (44)
Anesthesia for stereotactic radiosurgery in children. (1995) (43)
Radiotherapy-Induced Ocular Surface Disease (2005) (43)
High-grade astrocytomas. (1995) (43)
Occupational exposure to magnetic fields and the risk of brain tumors. (2009) (43)
Fractionated stereotactic radiotherapy. (1996) (42)
Consensus statement on stereotactic radiosurgery: quality improvement. (1994) (41)
Stereotactic radiosurgery and radiotherapy: new developments and new directions. (1997) (41)
Pre-irradiation chemotherapy for infants and children with medulloblastoma: a preliminary report. (1989) (40)
Long-Term Follow-Up of Patients Treated with Stereotactic Radiosurgery for Single or Multiple Brain Metastases1 (1996) (40)
Radiosurgery plus whole-brain radiation therapy for brain metastases. (2006) (39)
Genomic Profiling of Atypical Meningiomas Associates Gain of 1q With Poor Clinical Outcome (2009) (39)
Cranial stereotactic radiosurgery: current status of the initial paradigm shifter. (2014) (39)
Permanent low-activity iodine-125 implants for cerebral metastases (1997) (38)
Single-fraction proton beam stereotactic radiosurgery for cerebral arteriovenous malformations. (2014) (38)
Phase I trial of the hypoxic cell cytotoxin tirapazamine with concurrent radiation therapy in the treatment of refractory solid tumors. (1999) (38)
The acute onset of nausea and vomiting following stereotactic radiosurgery: correlation with total dose to area postrema. (1989) (37)
Brain metastases in patients with breast cancer: new horizons. (2005) (37)
Human Radiation Injury (2010) (37)
What is appropriate therapy for a patient with a single brain metastasis? (1994) (37)
A 10-year experience of pediatric brachytherapy. (1995) (37)
Single-nucleus and spatial transcriptome profiling of pancreatic cancer identifies multicellular dynamics associated with neoadjuvant treatment (2022) (35)
Histopathological prognostic factors of recurrence following definitive therapy for atypical and malignant meningiomas. (2017) (35)
Growth hormone deficiency after treatment of acromegaly: a randomized, placebo-controlled study of growth hormone replacement. (2010) (34)
Planned two-fraction proton beam stereotactic radiosurgery for high-risk inoperable cerebral arteriovenous malformations. (2012) (34)
The role of whole brain radiation in primary CNS lymphoma. (2016) (33)
Stereotactic radiotherapy: a technique for dose optimization and escalation for intracranial tumors. (1994) (33)
The prevention of radiosurgery-induced nausea and vomiting by ondansetron: evidence of a direct effect on the central nervous system chemoreceptor trigger zone. (1994) (32)
Long-term outcomes of patients with spinal cord gliomas treated by modern conformal radiation techniques. (2011) (32)
Proton Stereotactic Radiosurgery for Brain Metastases: A Single-Institution Analysis of 370 Patients. (2017) (32)
Repeat radiosurgery for cerebral arteriovenous malformations (2015) (31)
Treatment of spinal cord compression: a retrospective analysis. (1983) (31)
Underutilization of radiation therapy in patients with glioblastoma (2014) (31)
Treatment of perineural metastasis from squamous carcinoma of the skin with aggressive combination chemotherapy and irradiation (1985) (31)
Role of radiosurgery in the management of central nervous system metastases (1999) (30)
Radiosurgery and radiotherapy: observations and clarifications. (2004) (30)
Long-term outcomes and late adverse effects of a prospective study on proton radiotherapy for patients with low-grade glioma. (2019) (30)
Genetic variation in insulin-like growth factors and brain tumor risk. (2008) (30)
Prospective, Randomized Study of Radiation Dose Escalation With Combined Proton-Photon Therapy for Benign Meningiomas. (2017) (30)
Radiation Oncology: Technology and Biology (1994) (30)
A phase I trial of a new recombinant human beta-interferon (BG9015) for the treatment of patients with recurrent gliomas. (1997) (30)
The development of Graves' disease following radiation therapy in Hodgkin's disease. (1988) (30)
Increase of pseudoprogression and other treatment related effects in low-grade glioma patients treated with proton radiation and temozolomide (2018) (30)
A phase II trial of AZD2171 (cediranib), an oral pan-VEGF receptor tyrosine kinase inhibitor, in patients with recurrent glioblastoma (2007) (29)
Advances in radiation therapy for brain tumors. (1995) (29)
Study Design for a Case Control Investigation of Cellular Telephones and Other Risk Factors for Brain Tumors in Adults (1999) (29)
Single-nucleus and spatial transcriptomics of archival pancreatic cancer reveals multi-compartment reprogramming after neoadjuvant treatment (2020) (29)
Treatment-Induced Brain Tissue Necrosis: A Clinical Challenge in Neuro-Oncology. (2019) (29)
The added value of concurrently administered temozolomide versus adjuvant temozolomide alone in newly diagnosed glioblastoma (2008) (28)
The therapy of primary brain lymphoma (1991) (28)
The challenge of conformal radiotherapy in the curative treatment of medulloblastoma. (2000) (28)
Long-term impact of a faculty mentoring program in academic medicine (2018) (28)
Dose Escalation with Proton Radiation Therapy for High-Grade Meningiomas (2012) (28)
Metastatic epidural spinal cord compression: update on management. (2006) (28)
Beam shaping for conformal fractionated stereotactic radiotherapy: a modeling study. (1997) (28)
Personal hair dye use and risks of glioma, meningioma, and acoustic neuroma among adults. (2006) (27)
Stereotactic interstitial radiosurgery for cerebral metastases. (2005) (27)
Management of recurrent and refractory Cushing's disease with reoperation and/or proton beam radiosurgery. (2007) (27)
Stereotactic proton radiosurgery. (1999) (26)
Physics and biomedical challenges of cancer therapy with accelerated heavy ions (2021) (26)
A STAT3 Gene Expression Signature in Gliomas is Associated with a Poor Prognosis (2007) (26)
Genetic analyses for predictors of radiation response in glioblastoma. (2005) (26)
The case for radiosurgery. (1999) (26)
Central nervous system cancers. (2011) (25)
Radiosurgery for the treatment of intracranial lesions. (1995) (23)
Historical vignette: The radium bomb: Harvey Cushing and the interstitial irradiation of gliomas. (1996) (23)
Volumetric and actuarial analysis of brain necrosis in proton therapy using a novel mixture cure model. (2019) (23)
It is time to reevaluate the management of patients with brain metastases. (2014) (22)
Survival results from a phase I study of etanidazole (SR2508) and radiotherapy in patients with malignant glioma. (1998) (22)
Radiosurgery for metastases (1996) (22)
Stereotactic Irradiation: potential new treatment method for brain metastases resulting from ovarian cancer. (1999) (22)
Radiosurgery for intracranial vascular malformations: techniques, results, and complications. (1992) (22)
Dose-volume histogram computations for small intracranial volumes. (1993) (22)
Proton beam stereotactic radiosurgery for pediatric cerebral arteriovenous malformations. (2014) (21)
Cancer of the nervous system (2013) (21)
Laterality of Brain Tumors (2003) (20)
Defining Treatment‐Related Adverse Effects in Patients with Glioma: Distinctive Features of Pseudoprogression and Treatment‐Induced Necrosis (2020) (20)
De novo development of a cerebral arteriovenous malformation following radiation therapy: Case report and an update to classical arteriovenous malformation nomenclature (2016) (20)
Extracranial metastatic glioblastoma: appearance on thallium-201-chloride/technetium-99m-HMPAO SPECT images. (1991) (19)
Adjuvant radiotherapy versus surveillance following surgical resection of atypical meningiomas. (2020) (19)
Radiosurgery for glioblastoma multiforme: the importance of selection criteria. (1994) (19)
The emergence of conformal radiotherapy: special implications for pediatric neuro-oncology. (1999) (19)
Radiation optic neuropathy after proton beam therapy for optic nerve sheath meningioma. (2013) (19)
Radiation and chemotherapy for high‐risk lower grade gliomas: Choosing between temozolomide and PCV (2019) (19)
Phase 2 study of pembrolizumab in patients with recurrent and residual high-grade meningiomas (2022) (18)
Natural history and role of radiation in patients with supratentorial and infratentorial WHO grade II ependymomas: results from a population-based study (2013) (18)
MicroRNA-378 enhances radiation response in ectopic and orthotopic implantation models of glioblastoma (2017) (18)
Brain metastases (2005) (18)
Craniopharyngioma: Preliminary Results of Stereotactic Radiation Therapy (1996) (18)
Primary tumors of the heart: a review with emphasis on diagnosis and potential treatment modalities. (1985) (18)
The Relationship between Occlusive Hyperemia and Complications Associated with the Radiosurgical Treatment of Arteriovenous Malformations: Report of Two Cases (2004) (18)
Technological advances in radiation oncology for central nervous system tumors. (2009) (17)
Recent trends in the radiotherapy of pediatric gliomas (1996) (17)
The effects of irradiation on major histocampatibility complex expression and lymphocytic infiltration in the normal rat brain and the 9L gliosarcoma brain tumor model (1990) (17)
Pretreatment growth rate predicts radiation response in vestibular schwannomas. (2014) (17)
Late effects of CNS radiation therapy. (2009) (17)
Primary dural lymphomas: Clinical presentation, management, and outcome (2020) (17)
Therapeutic avenues for cancer neuroscience: translational frontiers and clinical opportunities. (2022) (16)
Brain metastases. (2000) (16)
A phase I-B trial of the radiosensitizer: etanidazole (SR-2508) with radiosurgery for the treatment of recurrent previously irradiated primary brain tumors or brain metastases (RTOG Study 95-02). (2008) (16)
Development of Lhermitte's sign after bone marrow transplantation (1992) (16)
Spatiotemporal Fractionation Schemes for Irradiating Large Cerebral Arteriovenous Malformations. (2016) (16)
The role of radiosurgery for glial neoplasms. (1999) (15)
Final report of the phase I trial of continuous infusion etanidazole (SR 2508): a Radiation Therapy Oncology Group study. (1992) (15)
Brachytherapy as an Adjuvant for Recurrent Atypical and Malignant Meningiomas. (2019) (15)
Multiple brain metastases. American College of Radiology. ACR Appropriateness Criteria. (2000) (15)
Update of radiation therapy oncology group (RTOG) protocol 9005: Single dose radiosurgical treatment of recurrent brain tumors (1998) (15)
Bone Involvement Predicts Poor Outcome in Atypical Meningioma (2008) (15)
The impact of different stereotactic radiation therapy regimens for brain metastases on local control and toxicity (2017) (14)
Optimal fractionation schedules in small field radiotherapy. (1994) (14)
NCCN Task Force (2009) (14)
Modeling Intracranial Second Tumor Risk and Estimates of Clinical Toxicity with Various Radiation Therapy Techniques for Patients with Pituitary Adenoma (2011) (14)
Craniopharyngioma in an elderly patient (1987) (13)
A phase I study of etanidazole and radiotherapy in malignant glioma. (1994) (13)
Whole abdominal irradiation for tumors of the uterine corpus (1988) (13)
Practice parameters for the management of single brain metastasis. (2000) (13)
Combining losartan with radiotherapy increases tumor control and inhibits lung metastases from a HER2/neu-positive orthotopic breast cancer model (2021) (12)
Do the dietary supplements epigallocatechin gallate or vitamin e cause a radiomodifying response on tumors in vivo? A pilot study with murine breast carcinoma. (2007) (12)
Distribution of etanidzole into human brain tumors: Implications for treating high grade gliomas (1992) (12)
Pre-irradiation evaluation and management of brain metastases. American College of Radiology. ACR Appropriateness Criteria. (2000) (12)
Novel radiation technologies for malignant gliomas. (1999) (12)
C11 Methionine PET (MET-PET) Imaging of Glioblastoma for Detecting Postoperative Residual Disease and Response to Chemoradiation Therapy. (2018) (12)
Patterns of Failure Among Patients With Low-grade Glioma Treated With Proton Radiation Therapy. (2019) (12)
Brachytherapy in the treatment of recurrent aggressive falcine meningiomas (2015) (11)
Image-Guided Diagnosis and Treatment of Cancer (2003) (11)
MR Spectroscopic Changes in the Rat Hippocampus following Proton Radiosurgery (2006) (11)
Characterization of blood vessels in brain autopsies of GBM patients who received antiangiogenic treatment (2008) (11)
Abstract LB-247: A multidisciplinary phase II study of AZD2171 (cediranib), an oral pan-VEGF receptor tyrosine kinase inhibitor, in patients with recurrent glioblastoma (2008) (10)
The influence of Harvey Cushing on neuroradiologic therapy. (1996) (10)
Follow-up and retreatment of brain metastasis. American College of Radiology. ACR Appropriateness Criteria. (2000) (10)
Linac radiosurgery at the Joint Center for Radiation Therapy. (1998) (10)
2098 Is there a role for cranial radiotherapy after primary high dose intravenous methotrexate in primary central nervous system lymphoma (1999) (10)
Reoperation following Radiosurgery of Glioblastoma: Impact on Survival and Neurologic Status (1996) (9)
MRI Changes in the Rat Hippocampus following Proton Radiosurgery (2004) (9)
A stereotactic radiation therapy device for retinoblastoma using a noncircular collimator and intensity filter. (1998) (9)
Temozolomide therapy for aggressive functioning pituitary adenomas refractory to surgery and radiation: a case series. (2018) (9)
Comments about the prospective randomized trial by Aoyama et al. (2006) (9)
Chemoradiation and adjuvant chemotherapy for glioblastoma: why does so much therapy yield so little improvement in survival? (1995) (8)
Autocrine regulation of the production of the gaseous messenger nitric oxide in a glioblastoma cell line. (1994) (8)
Advances in Radiosurgery (1994) (8)
Stereotactic techniques in managing pediatric brain tumors (1993) (8)
Hypopituitarism After Cranial Irradiation for Meningiomas: A Single-Institution Experience. (2019) (7)
Recurrent brain metastases. (1996) (7)
Technical modifications required to treat cervical chemodactomas with stereotactic radiosurgery. (1994) (7)
Proton therapy for head and neck paragangliomas: A single institutional experience (2019) (7)
Dual isotope single-photon emission computerized tomography used for prediction of histology and survival in patients after high-dose radiotherapy for malignant astrocytoma (1996) (7)
Erratum to: The role of stereotactic radiosurgery in the management of patients with newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline (2010) (7)
The potential for proton therapy to improve clinical outcomes: Comparisons of proton and x-ray treatment plans for the purpose of tumor dose escalation and/or reduction of treatment-related morbidity (2000) (7)
A Dynamic Collimator System for Conformal Stereotactic Radiosurgery and Radiotherapy (1996) (7)
NCCN adult brain tumor practice guidelines. (1997) (7)
Advances in the diagnosis and management of pituitary tumors. (1995) (7)
Treating brain metastases: current approaches and future directions (2004) (7)
Hypofractionated Stereotactic Radiotherapy for Recurrent Gliomas in Children and Adults: A Biological Compromise between Radiosurgery and Conventionally Fractionated Radiotherapy (1996) (6)
Single-fraction stereotactic radiosurgery for intracranial targets. (2006) (6)
Editorial: Charged Particles in Oncology (2017) (6)
Brain-specific RBE of Protons Based on Long-term Outcome of Patients with Nasopharyngeal Carcinoma. (2021) (6)
9 Radiosurgical treatment of previously irradiated primary brain tumors and brain metastasis: Final report of radiation therapy oncology group (RTOG) protocol 90-05 (1995) (6)
Selling a medical school's name: ethical and practical dilemmas. (2008) (6)
Cranial neuropathies following radiosurgery for cavernous sinus lesions: joint center for radiation therapy and university of Pittsburgh experience (1992) (6)
Radiosurgery for benign tumors and arteriovenous malformations of the central nervous system. (2001) (6)
Impact of molecular profiling on clinical trial design for glioblastoma (2007) (6)
Stereotactic radiosurgery improves survival in malignant gliomas compared with the RTOG recursive partitioning analysis (1994) (6)
Radiosurgery patterns of practice. (1995) (6)
Pan-cancer Transcriptomic Predictors of Perineural Invasion Improve Occult Histopathologic Detection (2021) (5)
Treatment Planning Support for Dynamic LINAC Stereotactic Delivery (1996) (5)
Early experience with stereotactic radiation therapy in the management of intracranial lesions: The first 1200 treatments (1993) (5)
Selected human leukocyte antigen class II polymorphisms and risk of adult glioma (2011) (5)
Arteriovenous malformations: indications for stereotactic radiosurgery. (2000) (5)
Can combined whole brain radiation therapy and radiosurgery improve the treatment of single brain metastases? (2004) (5)
Results of radiosurgery used in the initial management of patients with malignant gliomas (1991) (5)
Circulating Lymphocyte Counts Early During Radiotherapy are Associated with Recurrence in Pediatric Medulloblastoma. (2021) (5)
Post-operative radiation therapy to the surgical cavity with standard fractionation in patients with brain metastases (2020) (5)
Benign Meningiomas With Atypical Features: Correlation of Histopathological Features With Clinical Outcomes (2013) (4)
Outcome and Toxicity of Proton Therapy for Vestibular Schwannoma: A Cohort Study (2021) (4)
A STAT 3 Gene Expression Signature in Gliomas is Associated with a Poor Prognosis (2007) (4)
Normalization of Tumor Vasculature and Alleviation of Edema by AZD2171, A Pan-VEGF Receptor Tyrosine Kinase Inhibitor in Glioblastoma Patients (2007) (4)
Remote acute demyelination after focal proton radiation therapy for optic nerve meningioma (2015) (4)
Green eggs and ham: Strategies to address the growing phenomenon of selling a medical school's name. (2014) (4)
Subspecialization in radiation oncology: impact of stereotactic radiosurgery. (1992) (4)
Radiosurgery in the definitive management of CNS malignancies. (1993) (4)
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 33-2004. A 34-year-old man with a seizure and a frontal-lobe brain lesion. (2004) (4)
Study and Implementation of a Simple Beam Shaping System for Stereotactic Radiotherapy (1998) (4)
Brain metastases from breast cancer: Survival by HER2 status in the trastuzumab era (2004) (4)
2375 : Conformal Proton Radiotherapy for Primary Sphenoid Sinus Malignancies (2006) (4)
Dose-Volume Characteristics of Brain Lobe Late Response Following Proton-Photon Radiotherapy of Paranasal Sinus Cancer (2005) (4)
Solitary brain metastasis. American College of Radiology. ACR Appropriateness Criteria. (2000) (4)
Stereotactic Radiation as Salvage Therapy for Recurrent Rathke Cleft Cysts. (2020) (4)
Stereotactic Radiotherapy for Meningiomas (1996) (4)
Proton Beam Therapy (For CNS Tumors) (2018) (4)
High efficacy without visual damage: the current status of pituitary radiotherapy. (1995) (3)
Single Fraction Proton Beam Stereotactic Radiosurgery (PSRS) for Inoperable Cerebral Arteriovenous Malformations (AVMs) (2012) (3)
Distribution of etanidazole into human brain tumors: implications for treating high grade gliomas. (1992) (3)
Alternative and future strategies in the treatment of malignant gliomas (1991) (3)
Technology assessment in radiation oncology: time for reassessment? (2008) (3)
Facial numbness in a man with inguinal and retroperitoneal masses (2005) (3)
Thallium-201 Technetium-99m HMPAO single-photon emission computed tomography (SPECT) imaging for guiding stereotactic craniotomies in heavily irradiated malignant glioma patients (2005) (3)
Evolution of Radiation Oncology at Massachusetts General Hospital (2011) (3)
Primary non-Hodgkin's lymphoma of bone — factors that influence survival (1984) (3)
Stereotactic radiation for intracranial arteriovenous malformations. (1990) (3)
Stereotactic proton beam radiosurgery for ACTH producing adenomas in the MRI/CT era (2001) (3)
Neuroimaging in Radiosurgery Treatment Planning and Follow-up Evaluation (2008) (3)
eScholarship Title The role of stereotactic radiosurgery in the management of patients with newly diagnosed brain metastases : a systematic review and evidence-based clinical practice guideline (2010) (3)
Is fractionated stereotactic radiotherapy effective in pituitary adenomas? (2005) (3)
Correction to: Criteria for the definition of Pituitary Tumor Centers of Excellence (PTCOE): A Pituitary Society Statement (2018) (3)
Atypical histopathological features and the risk of treatment failure in non-malignant meningiomas: a multi-institutional analysis. (2019) (3)
Controversies in the management of patients with brain metastases. (2001) (3)
RADIOSURGERY IN THE MANAGEMENT OF INTRACRANIAL LESIONS: A RADIATION ONCOLOGY PERSPECTIVE (1992) (3)
Proceeding of the 37th Annual ASTRO meeting Abstract of scientific paper to be persented8 A multi-institutional outcome and prognostic factor analysis of radiosurgery (RS) for resectable single brain metastasis (1995) (3)
The Changing Landscape of Whole-Brain Radiation Therapy. (2015) (3)
135 Intracranial germinomas: A case for low dose radiation therapy alone (1995) (3)
Phase Ib study of cediranib in combination with daily temozolomide and radiation in patients with newly diagnosed glioblastoma. (2016) (3)
Efficacy and Risk for Radiotherapy for Pituitary Tumors (2002) (2)
Whole abdominal irradiation for tumors of the uterine corpus. (1988) (2)
Performance of a Hospital Pathway for Patients With a New Single Brain Mass. (2019) (2)
Proton Beam Radiosurgery and Radiotherapy (2003) (2)
Linac Radiosurgery for Meningiomas (1998) (2)
Equivalent uniform dose predicts delayed hyperintensity on T1-weighted magnetic resonance imaging after combined proton and photon irradiation in paranasal sinus cancer (2004) (2)
INCREASED PERFUSION DUE TO VASCULAR NORMALIZATION IMPROVES OXYGENATION AND SURVIVAL IN GLIOBLASTOMA PATIENTS TREATED WITH CEDIRANIB WITH OR WITHOUT CHEMORADIATION (2014) (2)
Gender, Productivity, and Philanthropic Fundraising in Academic Oncology. (2021) (2)
Biomathematics and Biostatistics (2011) (2)
2023 Survival results of a phase I study of etanidazole and radiotherapy in patients with malignant glioma (1996) (2)
Primary and Metastatic Brain Tumors (2015) (2)
Stereotactic radiosurgery treats intracranial lesions. (1994) (2)
Advantage of protons compared to IMRT in the treatment of medulloblastoma (2000) (2)
Fractionated Proton Radiation Therapy and Hearing Preservation for Vestibular Schwannoma: Preliminary Analysis of a Prospective Phase 2 Clinical Trial (2022) (2)
A randomized radiation dose escalation trial in patients with recurrent or incompletely resected benign meningiomas treated with proton-photon irradiation (2003) (2)
Patterns of Failure and Risk Factors for Recurrence Among Low-Grade Glioma Patients Treated With Proton Radiation Therapy (2017) (2)
Second Tumor Risk and Projected Late Effects after Proton vs. Intensity Modulated Photon Radiotherapy for Benign Meningioma: A Dosimetric Comparison (2010) (2)
Micro Intensity-Modulated Radiotherapy for Intracranial Tumors: A Case Study (2000) (2)
Cancer chemotherapy and radiation therapy (2010) (2)
Radiation Therapy for Pituitary Tumors (2017) (2)
Primary Intracranial Germ Cell Tumors (2006) (2)
Proton Radiation Therapy for Head and Neck Paragangliomas: A Single Institution Experience (2017) (2)
2080 Micro-IMRT for stereotactic radiotherapy of intracranial tumors (1999) (2)
Complication Rates after Radiosurgery for Cavernous Malformations (1998) (2)
The role of proton beam therapy in central neurocytoma: A single-institution experience. (2018) (1)
Case records of the Massachusetts General Hospital. Case 37-2008. A 17-year-old boy with a pituitary tumor and skull abnormalities. (2008) (1)
Positron emission tomography for the management of brain tumors (2004) (1)
Michael Goitein, 1939-2016: A Giant of Modern Medical Physics. (2017) (1)
Second Tumor Risk With Modern Radiotherapy for Pituitary Adenomas (2007) (1)
Title The role of retreatment in the management of recurrent / progressive brain metastases : A systematic review and evidence-based clinical practice guideline (2010) (1)
CHAPTER 54 – Proton Radiation Therapy for Meningiomas (2010) (1)
Radiation Therapy in the Management of Cushing’s Disease (2011) (1)
132 Initial clinical results of linac stereotactic radiosurgery (SRS) and stereotactic radiotherapy (SRT) for pituitary adenomas (1997) (1)
Proton Radiotherapy For Vestibular Schwannomas: A Cohort Study (2020) (1)
Brain metastases from breast cancer: Survival by HER2 status in the trastuzumab era. (2004) (1)
Does radiosurgery have a role in the treatment of acromegaly? (2008) (1)
Treatment of progressive neurofibromatosis type 2-related vestibular schwannoma with erlotinib (2008) (1)
Radiomodifying responses of vitamin E and epigallocatechin gallate supplementation during irradiation of implanted tumors. (2004) (1)
Advances in radiosurgery : proceedings of the 1st Congress of the International Stereotactic Radiosurgery Society, Stockholm 1993 (1994) (1)
CHAPTER 24 – Stereotactic Radiosurgery: Basic Principles, Delivery Platforms and Clinical Applications (2008) (1)
Wyburn–Mason Syndrome Variant Treated with Stereotactic Radiosurgery (1999) (1)
2386: Combined Modality Treatment With Proton Radiotherapy for Locally Advanced Sinonasal Squamous Cell Carcinoma (2006) (1)
The anti-epidermal growth factor receptor (EGFR) monoclonal antibody, C225, enhances radiation-induced apoptosis in primary glioma cell lines through mediation of MAPK/JNK/p38 signaling pathways (2001) (1)
Radiosurgery: Enhancement of Clinical Excellence: Harvard Radiosurgery Update Course, Boston, Mass., June 1990: Selected Proceedings (1992) (1)
Applications of Stereotactic Radiosurgery in Neuro-Oncology (2016) (1)
Cellular Telephones and Brain Tumors (2001) (1)
Lead, Genetic Susceptibility and Risk of Adult Brain Tumors (2006) (1)
724 Stereotactic Interstitial Radiosurgery for Cerebral Metastases (2001) (1)
Chiu-Chen Wang, M.D. (2006) (1)
69 Proton Beam Radiosurgery: Clinical Experience (2009) (1)
Combined Angiotensin Receptor Blocker Losartan and the CXCR4 Inhibitor AMD3100 Increases the Efficacy of Radiotherapy in a Metastatic Osteosarcoma Mouse Model (2018) (1)
Pathological Changes in Surgically Resected Angiographically Occult Vascular Malformations after Radiation (1998) (1)
Application of Current Radiation Delivery Systems and Radiobiology (2018) (1)
Radiosurgery as Salvage Therapy for Primary Central Nervous System Lymphoma (2010) (1)
Intraoperative Electron Radiation Therapy (2011) (1)
Proton Stereotactic Radiotherapy for Treatment of Nelson's Syndrome. (2021) (0)
Proton Radiosurgery for Management of Brain Metastases (2012) (0)
Insulin-like Growth Factor Receptor I Mediates Resistance to Anti-Epidermal Growth Factor Receptor Therapy in Primary Human Glioblastoma Cells through Continued Activation of Phosphoinositide 3-Kinase Signaling 1 (2001) (0)
Histopathologic Prognostic Factors of Recurrence Following Surgery and Radiation Therapy for Atypical and Malignant Meningiomas (2016) (0)
Radiation Therapy for Pituitary Adenomas (2008) (0)
Outcomes of Proton Radiation Therapy for Patients With Functional Pituitary Adenomas (2013) (0)
Technical Aspects of a Proton Stereotactic Radiosurgery Program (2014) (0)
Proton radiosurgery in the management of functioning and non-functioning pituitary adenomas: A 10-year experience at the massachusetts general hospital (2004) (0)
Early Culture and Medicine to 1895 and the Creation of the MGH (2011) (0)
Radiobiology of Stereotactic Radiosurgery (2009) (0)
Quality of Life in Patients Treated With Surgery Alone Versus Surgery and Radiation for Nonfunctioning Pituitary Adenomas (2014) (0)
2. To make recommendations based on this evidence for the role of surgery in the management of these patients. (2010) (0)
Radiation Therapists, Nurses, Medical Records, Receptionists and Cox Front Door Welcoming Team (2011) (0)
Prognostic factors of adult medulloblastoma in the MRA ERA (1998) (0)
NTOX-06. INCREASE OF PSEUDOPROGRESSION AND TREATMENT RELATED EFFECTS IN LOW-GRADE GLIOMA PATIENTS TREATED WITH PROTON RADIATION AND TEMOZOLOMIDE (2017) (0)
Chapter 45 – Application of Current Radiation Delivery Systems and Radiobiology (2012) (0)
Abstracts of the 6th Canadian Neuro-Oncology Meeting May 18–21, 1994 Lake Louise, Alberta (1994) (0)
Dynamic Changes in Arteriovenous Malformations (AVMs): Spontaneous Growth and Resolution of AVM-Associated Aneurysms in Two Pediatric Patients (2019) (0)
The New Optimism After WWII and the Decision for a Cancer Center at MGH 1945–1970 (2011) (0)
Fractionated Proton Beam Radiation Therapy and Hearing Preservation for Vestibular Schwannoma: Preliminary Analysis of a Prospective Phase 2 Clinical Trial. (2021) (0)
In response to Dr. Goffman (2005) (0)
Patterns Of Failure And Prognostic Factors Of Adult Medulloblastoma Treated With Radiation Therapy (2020) (0)
Reassessment of the Role of Radiation Therapy in the Treatment of Endocrine-inactive Pituitary Macroadenomas (1998) (0)
INTRODUCTION — Most meningiomas are benign, but their location in the central nervous system can cause serious morbidity and/or mortality. The epidemiology, risk factors, and pathologic classification of meningiomas will be reviewed here. Other topics on meningioma include: (2013) (0)
Genetic determinants of radiation response in glioblastoma (2004) (0)
Intracranial neoplasms can arise from any of the structures or cell types present in the cranial vault, including the brain, meninges, pituitary gland, skull, and even residual embryonic tissue. (2015) (0)
Radiosurgery for brain tumours (1999) (0)
314 Stereotactic radiosurgery: Results and current trends (1995) (0)
Post-Operative Cavity Radiation Therapy with Standard Fractionation for Brain Metastases (2018) (0)
The treatment of patients with large inoperable AVMs (1998) (0)
Clinical Advances by the MGH Department of Radiation Oncology (2011) (0)
The Radiogenomic Landscape of Cancer (2014) (0)
GAMMA KNIFE SURGERY FOR LOW-GRADE GLIOMAS. Commentaries (2005) (0)
Two-Fraction Proton Beam Stereotactic Radiosurgery for Cerebral Arteriovenous Malformations. (2021) (0)
Radiosurgery for the treatment of intracraniallesions (2017) (0)
Patrons of the Department (2011) (0)
Novel gene expression patterns associated with progression and adverse outcome in high-grade gliomas (2005) (0)
Long-Term Outcomes of a Prospective Trial on Proton Therapy for Low-Grade Glioma (2017) (0)
Nitric oxide (no) production by a glioblastoma (GBM) cell line: Possible implications for pathogenesis and radiation therapy (1993) (0)
This report contains the toxicity and survival rates for 38 patients with GBM who were treated with BNCT (1999) (0)
Phase I I T rial o f t he A ntiangiogenic A gent T halidomide i n Patients W ith R ecurrent H igh-Grade G liomas (2000) (0)
C11 Methionine Positron Emission Tomography (MET-PET) Imaging of Glioblastoma for Detecting Postoperative Residual Disease and Response to Chemoradiation Therapy (2016) (0)
NRF2 Is a Novel Oncogene and Biomarker of Therapeutic Resistance in Non-Small Cell Lung Cancer (2014) (0)
TH‐EF‐BRD‐10: Spatiotemporal Dose Shaping to Achieve Uniform Fractionation in Healthy Tissues Along with Hypo‐Fractionation in Targets (2015) (0)
Radiation Therapy for Brain Metastases in Non-Small Cell Lung Cancer: Significance of Mutations in EGFR, ALK, or KRAS on Radiation Therapy Response and Survival (2013) (0)
Brachytherapy for Recurrent High-grade Meningiomas: An Institutional Experience (2017) (0)
Case 10-1984: orbital rhabdomyosarcoma. (1984) (0)
Chapter 160 – Malignant Gliomas (2003) (0)
Non invasive immobilization frames for stereotactic radiotherapy: Modifications of the gill-thomas frame and development of a pediatric frame (1993) (0)
Radiotherapy for Glioblastoma Modestly Beneficial in Elders (2007) (0)
Radiation Therapy in Patients With Cushing Disease (2019) (0)
Radiation Oncology and the MGH 1896–1945 (2011) (0)
Photon and Electron Physics at MGH 1975–2008 (2011) (0)
415C Stereotactic radiosurgery — part II: Clinical experience and future directions (1996) (0)
eScholarship Title The role of whole brain radiation therapy in the management of newly diagnosed brain metastases : a systematic review and evidence-based clinical practice guideline (2010) (0)
P01.05 Current clinical use of daptomycin in Europe from the European Cubicin® Outcomes Registry and Experience (EU-CORE) (2010) (0)
NRF2 Is a Novel Oncogene and Biomarker of Therapeutic Resistance in Non-Small Cell Lung Cancer : Novel Therapies/Experimental Therapies (2014) (0)
Future of the Department of Radiation Oncology at the MGH (2011) (0)
Long-term outcomes and late toxicity of adult medulloblastoma treated with combined modality therapy: a contemporary single-institution experience. (2022) (0)
Poster ViewingCNS Hemangiopericytoma/Solitary Fibrous Tumor: Late Local Recurrence and Distant Failures Continue to Increase With Time Following Definitive Management (2017) (0)
Adjuvant Radiation Therapy Is Associated With Survival Benefit in WHO Grade 3 Astrocytomas But Not Oligodendrogliomas: Results From a Population-Based Study (2013) (0)
Stereotactic conformal radiation therapy in the treatment of benign and low-grade brain tumors (2017) (0)
Response to Wollin et al. (1990) (0)
SRS for Nonfunctioning Pituitary Adenomas (2021) (0)
L19 01 TA – THE ROLE OF RADIOSURGERY IN THE MANAGEMENT OF INTRACRANIAL LESIONS - A RADIATION ONCOLOGY PERSPECTIVE (1991) (0)
P21.07 Temozolomide for Progressive Pituitary Adenomas Refractory to Surgery and Radiation: A Case Series (2016) (0)
Long-term Outcomes and Late Adverse Effects of a Prospective Study on Proton Therapy for Patients with Low-Grade Glioma (2019) (0)
RADT-24. PHASE II STUDY OF PROTON RADIATION THERAPY FOR LOWER GRADE GLIOMAS (2022) (0)
Timing of Adjuvant Radiotherapy in Atypical Meningiomas (2020) (0)
Proton therapy in Europe (2005) (0)
Post-operative radiation therapy to the surgical cavity with standard fractionation in patients with brain metastases (2020) (0)
Phase II Tria l o f the Ant iangiogenic Agent Thal idomide in Pat ients With Recurrent High-Grade Gl iomas (2000) (0)
Cancer Management Chapter 23: Primary and metastatic brain tumors (2010) (0)
When should proton radiation therapy be used to treat brain tumors? (2012) (0)
Appearanceon Thaffium-201-Chloride/ Technetium-99m@HMPAO SPECTImages (1991) (0)
Special Social Functions (2011) (0)
Mixed Proton and Photon Therapy for Benign Meningiomas: Long-term Results of a Prospective Randomized Dose Escalation Study (2013) (0)
Proton Radiosurgery: A Clinical Transition From Passive Scattering to Pencil Beam Scanning. (2021) (0)
Brain-specific End-of-range RBE Based on Long-term Follow-up of Patients with Nasopharyngeal Carcinoma (2019) (0)
Radiation Biology of Tumor and Normal Tissues (2011) (0)
Subject Index Vol. 21, 1994 (1994) (0)
Commentary (Loeffler/Shrieve): An Overview of Radiotherapy Trials for the Treatment of Brain Metastases (1995) (0)
Title The role of stereotactic radiosurgery in the management of patients with newly diagnosed brain metastases : A systematic review and evidence-based clinical practice guideline (2010) (0)
Pituitary tumors. (1990) (0)
811 Multimodality Treatment Approach in 424 Arteriovenous Malformations (AVMs): Improved Outcome in High Risk Lesions. (2000) (0)
Long-Term Outcome after Proton-Beam Radiosurgery for Vestibular Schwannoma (2012) (0)
The Epidermal Growth Factor Receptor Pathway Mediates Resistance to Sequential Administration of Radiation and Chemotherapy in Primary Human Glioblastoma Cells in a RAS-dependent Manner 1 (2002) (0)
Volumetric index of Tl-201 uptake in symptomatic patients after high - dose radiation treatment for high-grade gliomas (1995) (0)
Clinically Targetable Mutation Status Associated with Local Control Following Radiation Treatment for Brain Metastases (2017) (0)
Special Lecture Series (2011) (0)
1119 : Comparison of Fractionated Stereotactic Radiotherapy With Proton Radiosurgery for Vestibular Schwannoma: A Risk-Stratified Analysis (2006) (0)
The Impact of Different Hypofractionated Stereotactic Radiation Therapy Regimens for Brain Metastases on Local Control and Toxicity (2013) (0)
Proton Therapy for Low-grade Gliomas: A Pilot Study (2012) (0)
In vivo verification of proton beam delivery by PET-CT (2007) (0)
7 Altered p53 expression in radiation-associated intracranial malignancy (1996) (0)
The New Department of Radiation Oncology 1970–1975 (2011) (0)
Tumor Size Predicts Control of Benign Meningiomas Treated with Radiotherapy (1999) (0)
315C Stereotactic radiosurgery- part I: Physics and treatment planning (1996) (0)
Neuroendocrine Function Following Proton Therapy for Low-Grade Gliomas: Results From a Prospective Trial. (2016) (0)
Two-fraction Proton Beam Stereotactic Radiosurgery For High-Risk Inoperable Cerebral Arteriovenous Malformations (AVMs) (2011) (0)
Radiosurgery versus Fractionated Stereotactic Radiotherapy for the Treatment of Vestibular Schwannoma (2008) (0)
Comprar Evolution of radiation oncology at massachusetts general hospital | H. Suit | 9781441967435 | Springer (2011) (0)
Proton Therapy Program (2011) (0)
Survivin increases resistance to radiation-induced cell death and is upregulated by AKT signaling in primary human glioblastoma cell lines (2002) (0)
2874 : Clinical Feasibility of PET/CT Image Guidance After Proton Radiotherapy (2006) (0)
Phase II Study Of Proton Radiation Therapy For Lower Grade Gliomas (2020) (0)
Radiosurgery: enhancement of clinical excellence. Introduction. (1991) (0)
Tumors of the Central Nervous System (2017) (0)
Conventionally fractionated stereotactic radiotherapy for vestibular schwannoma: long-term outcome and cranial nerve function (2001) (0)
Radiation Therapy and Malignant Degeneration of Benign Supratentorial Gangliogliomas (1998) (0)
Outcomes of Patients with Benign Meningiomas Treated with Proton Stereotactic Radiosurgery (2008) (0)
283Conformal radiation therapy: Current status and applications (1996) (0)
2242 Stereotactic radiosurgery (SRS) in the management of pediatric brain tumors (1999) (0)
Atypical Histopathological Features and the Risk of Progression/Recurrence in WHO Grade I-II Meningiomas (2018) (0)
Combining losartan with radiotherapy increases tumor control and inhibits lung metastases from a HER2/neu-positive orthotopic breast cancer model (2021) (0)
Abstracts from the Joint Section on Tumors (2004) (0)
AT-52PROSPECTIVE EARLY RESULTS OF LOW GRADE GLIOMA PATIENTS TREATED WITH PROTON THERAPY (2014) (0)
RAS-dependent Manner Chemotherapy in Primary Human Glioblastoma Cells in a Resistance to Sequential Administration of Radiation and The Epidermal Growth Factor Receptor Pathway Mediates (2002) (0)
Response to Dr. Patchell (1994) (0)

This paper list is powered by the following services:

Other Resources About Jay Loeffler

en.wikipedia.org

What Schools Are Affiliated With Jay Loeffler?

Jay Loeffler is affiliated with the following schools:

Jay Loeffler's Academic­Influence.com Rankings